Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Back to Our thinking

English
中文
Deutsch
Español
Français
日本語
Português

News

FDA Device Guidance Agenda: What to Watch in 2026

15 October 2025

Insights and Analysis

Initial reflections on Law 132/25: Italy's approach to AI

15 October 2025

Insights and Analysis

FDA seeks public comment on monitoring strategies for AI-enabled devices

09 October 2025

News

Impact of Government Shutdown on FDA and FSIS Activities

01 October 2025

News

What an FY 2026 federal government shutdown will mean for FDA

29 September 2025

News

Section 232 tariff investigation: What medical device manufacturers and importers need to know

26 September 2025

News

FDA ramps up drug ad enforcement, targets social media

11 September 2025

News

MAHA Commission Releases Make Our Children Healthy Again Strategy

10 September 2025

Insights and Analysis

New perspectives on handling decommissioning liabilities & risks for end-of-life energy, mining, industrial, waste management and shipping assets

10 September 2025

News

Instructing occupational health

08 September 2025

Insights and Analysis

New FDA approval process promotes development of rare disease gene therapies

05 September 2025

Digital Client Solutions

Empowering you to lead change through our digital solutions.

Learn more

Our thinking

News

Insights and Analysis

Insights and Analysis

News

News

News

News

News

Insights and Analysis

News

Insights and Analysis

No results found